🇺🇸 FDA
Pipeline program

DCC-3014, DCC-3014, DCC-3014

DCC-3014-01-001

Phase 2 small_molecule active

Quick answer

DCC-3014, DCC-3014, DCC-3014 for Patients with Advanced Tumors and Tenosynovial Giant Cell Tumor is a Phase 2 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Lacuna Pharma Pty Ltd
Indication
Patients with Advanced Tumors and Tenosynovial Giant Cell Tumor
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials